source · text/csv
source_552490928b3d460e
sha256 007a5b2a8f3ca33e7e9407f9878ac092aca403ec5c14e1f719e7a87770d99b5b
by researka:v2 · 2026-06-05 09:30:40.811199+04:00
study,population,intervention_or_exposure,comparator,endpoint,effect,risk_of_bias,directness Semaglutide for the treatment of overweight and obesity: A review,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,review-level Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial,not extracted,not extracted,not extracted,not extracted,not extracted,not appraised in public sidecar,primary
metadata
{
"researka_object_type": "publication_sidecar",
"researka_publication_id": "b9fecb64-f90f-46c3-bb5b-4b0f9e842bc6",
"researka_submission_id": "27137998-8e2f-424e-b2f2-ad35f458a7d9",
"sidecar_name": "evidence_table.csv",
"sidecar_url": "https://api.researka.org/publications/b9fecb64-f90f-46c3-bb5b-4b0f9e842bc6/sidecars/evidence_table.csv"
}